chr6-7583758-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_StrongPP5_Very_Strong
The NM_004415.4(DSP):c.6496C>T(p.Arg2166*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004415.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.6496C>T | p.Arg2166* | stop_gained | Exon 24 of 24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001319034.2 | c.5167C>T | p.Arg1723* | stop_gained | Exon 24 of 24 | NP_001305963.1 | ||
DSP | NM_001008844.3 | c.4699C>T | p.Arg1567* | stop_gained | Exon 24 of 24 | NP_001008844.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.6496C>T | p.Arg2166* | stop_gained | Exon 24 of 24 | 1 | NM_004415.4 | ENSP00000369129.3 | ||
DSP | ENST00000418664.2 | c.4699C>T | p.Arg1567* | stop_gained | Exon 24 of 24 | 1 | ENSP00000396591.2 | |||
DSP | ENST00000710359.1 | c.5167C>T | p.Arg1723* | stop_gained | Exon 24 of 24 | ENSP00000518230.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251438Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135908
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727234
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74298
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg2166*) in the DSP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 706 amino acid(s) of the DSP protein. This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with arrhythmogenic right ventricular dysplasia/cardiomyopathy and acantholytic epidermolysis bullosa (PMID: 23671136, 27532257, 28442525). ClinVar contains an entry for this variant (Variation ID: 199903). This variant disrupts a region of the DSP protein in which other variant(s) (p.Glu2728Glyfs*11) have been determined to be pathogenic (internal data). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Cardiomyopathy Pathogenic:1
This variant changes 1 nucleotide in exon 24 of the DSP gene, creating a premature translation stop signal in the last exon. This variant alters C-terminal plakin repeat domains A, B and C that are essential for coalignment and binding of intermediate filaments (PMID: 12101406, 21756917) and is expected to disrupt protein function. This variant has been reported in at least three individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 23671136, 25820315, 27532257, 28588093, 29759408), in an individual affected with arrhythmogenic left ventricular cardiomyopathy (PMID: 35444050), and in another two individuals affected with dilated cardiomyopathy (PMID: 32969603, 37461109). This variant has been identified in 2/251438 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of DSP function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
DSP-related cardiomyopathy Pathogenic:1
The DSP c.6496C>T (p.Arg2166Ter) nonsense variant results in the loss of normal protein function through protein truncation. This variant occurs in the last exon of the gene and may escape nonsense-mediated mRNA decay. This variant has been identified in a heterozygous state in individuals with arrhythmogenic right ventricular cardiomyopathy (PMID: 23671136; 27532257) and dilated cardiomyopathy (PMID:32969603). This variant is not observed at a significant frequency in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. This variant has been previously classified as pathogenic by at least three submitters in ClinVar. Based on the available evidence, the c.6496C>T (p.Arg2166Ter) variant is classified as likely pathogenic for DSP-related cardiomyopathy. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23810894, 23671136, 27532257, 31386562, 31402444, 33087929, 23871885, 32969603, 28442525, 36264615, 34352074) -
Cardiovascular phenotype Pathogenic:1
The p.R2166* pathogenic mutation (also known as c.6496C>T), located in coding exon 24 of the DSP gene, results from a C to T substitution at nucleotide position 6496. This changes the amino acid from an arginine to a stop codon within coding exon 24. This alteration occurs at the 3' terminus of theDSP gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 25% of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). Alterations in DSP that result in haploinsufficiency or protein truncation have been reported in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM) (Fressart V et al. Europace. 2010;12(6):861-8; Elliott P et al. Circ Cardiovasc Genet. 2010;3(4):314-22; Quarta G et al. Circulation. 2011;123(23):2701-9; Garcia-Pavia P et al. Heart. 2011;97(21):1744-52; Rasmussen TB et al. Clin Genet. 2013;84(1):20-30; Pugh TJ et al. Genet Med. 2014;16(8):601-8). This alteration has been identified in an individual meeting definite arrhythmogenic right ventricular cardiomyopathy (ARVC) Task Force Criteria (Bhonsale A et al. Circ Arrhythm Electrophysiol, 2013 Jun;6:569-78; Groeneweg JA et al. Circ Cardiovasc Genet, 2015 Jun;8:437-46). This variant has also been reported in monozygotic twins with acantholytic epidermolysis bullosa, who had another truncating DSP variant detected in trans (Kim SJ et al. Ann Clin Lab Sci, 2017 Mar;47:213-216). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at